Natera unentitled to discretionary denial of patent review, rival tells USPTO
MLex Summary: Inter partes review petitioner NeoGenomics Laboratories is opposing a request by Natera for a discretionary denial of a challenge to Natera's US Patent No. 11,319,596.See attached document....To view the full article, register now.
Already a subscriber? Click here to view full article